Oramed Pharmaceuticals, Inc. (ORMP)
3.88
+0.02
(+0.52%)
USD |
NASDAQ |
Apr 17, 16:00
3.89
+0.01
(+0.26%)
After-Hours: 20:00
Oramed Pharmaceuticals Free Cash Flow : -9.709M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Lifeward Ltd. | -16.84M |
| Bristol Myers Squibb Co. | 12.84B |
| Merck & Co., Inc. | 12.36B |
| Instil Bio, Inc. | -46.62M |
| Moderna, Inc. | -2.075B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.6243M |
| Cash from Investing (Quarterly) | -1.679M |
| Cash from Financing (Quarterly) | -4.263M |
| Free Cash Flow Per Share (Quarterly) | -0.0155 |
| Free Cash Flow to Equity (Quarterly) | -0.5915M |
| Free Cash Flow to Firm (Quarterly) | -0.6265M |
| Free Cash Flow Yield | -5.99% |